Keywords: Diagnosis/Prediction, Machine Learning/Artificial Intelligence
Motivation: Prostate cancer has diverse genetic subtypes affecting prognosis and treatment response.
Goal(s): Develop a machine learning model to predict four genetic subtypes (Luminal A, Luminal S, AVPC-I, ACPV-M) using radiomic features from T2-weighted MRI, supporting personalized treatment.
Approach: In 195 patients, RNA sequencing identified subtypes. T2-weighted MRIs were segmented, and 1,422 radiomic features were extracted. Feature selection used ICC, and classification models were trained with SMOTE for data balance.
Results: The RF model achieved AUROC scores of 0.98 (train) and 0.84 (test) for AR inhibitor-resistant subtype, and 0.95 (train) and 0.77 (test) for differentiating docetaxel-resistant subtypes.
Impact: Our pilot study demonstrated promising results for a radiomics model capable of predicting genetic subtypes of prostate cancer. This model demonstrated its ability to predict AR inhibitor-resistant and docetaxel-resistant genetic subtypes with AUROCs of 0.84 and 0.77, respectively.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords